ABG Acquisition Corp. I has priced its initial public offering of 13,100,000 Class A ordinary shares at a price of $10.00 per share. The shares will be listed on the Nasdaq Capital Market and trade under the ticker symbol “ABGI” beginning February 17. The company has granted the underwriter a 45-day option to purchase up to an additional 1,965,000 Class A ordinary shares at the initial public offering price to cover over-allotments, if any. The company intends to focus on the global healthcare industry, with a particular focus on the medical technology and biotechnology verticals. ABG is led by its chief executive officer, Fan Yu, and its chief financial officer, Daniel Johnson.
Jefferies LLC acted as the sole book-running manager of the offering.